Malta vs North America: Tuberculosis treatment success rate
Tuberculosis treatment success rate over time
- Malta
- North America
How they compare
Malta currently reports 98.0% against 79.0% in North America, a difference of 19.0%.
That makes Malta's figure about 1.2 times North America's.
The two have swapped places 6 times across 16 shared years of data; in 2000 it was Malta ahead.
Malta ranks 14th and North America ranks 15th of 203 countries.
Across the 3 decades both report, Malta averaged higher in 2 and North America in 1.
Head to head by decade
| Decade | Malta | North America | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 87.3% | 79.5% | 7.8% | Malta |
| 2010s | 58.5% | 77.8% | 19.2% | North America |
| 2020s | 98.5% | 75.0% | 23.5% | Malta |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis treatment success rate, Malta or North America?
- Malta, at 98.0% against 79.0% in North America as of 2021.
- What is the difference in tuberculosis treatment success rate between Malta and North America?
- 19.0%, with Malta ahead.
- How many years of comparable data are there for Malta and North America?
- 16 years are reported by both, from 2000 to 2021.
- How do Malta and North America rank globally for tuberculosis treatment success rate?
- Malta ranks 14th and North America ranks 15th of 203 countries.
- Where does this data come from?
- Global Tuberculosis Report, World Health Organization (WHO), published as Tuberculosis treatment success rate (% of new cases). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Tuberculosis treatment success rate is the percentage of all new tuberculosis cases (or new and relapse cases for some countries) registered under a national tuberculosis control programme in a given year that successfully completed treatment, with or without bacteriological evidence of success ("cured" and "treatment completed" respectively).